We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medcaw Investments Plc | LSE:MCI | London | Ordinary Share | GB00BM8SQP62 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.25 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Offices-holdng Companies,nec | 0 | -712k | -0.0416 | -1.02 | 728.11k |
From Mar 2023 to Mar 2025
16th March 2023
Medcaw Investments Plc - 13078596
(“Medcaw Investments” or the “Company”)
Directors Dealing
Medcaw Investments Plc (LSE:MCI), a special purpose acquisition vehicle, announces that it has received notification that Marcus Yeoman, Non-executive Director, has acquired a total of 95,908 shares in the Company in the following transactions.
| Date | Shares acquired | Price per share |
| 14 March 2023 | 25,000 | 2.95p |
| 16 March 2023 | 35,816 | 3.49p |
| 16 March 2023 | 25,062 | 3.99p |
| 16 March 2023 | 10,030 | 4.985p |
Following the transactions, Marcus Yeoman is interested in 126,808 shares representing 0.74% of the Company’s issued share capital.
This announcement contains inside information for the purposes of UK Market Abuse Regulation. The persons who arranged the release of this information are the Directors of the Company.
*** ENDS ***
Enquiries:
Medcaw Investments Plc +44 (0)203 918 8797
Sarah Cope, Executive Chairperson
Zeus Capital Limited +44 (0) 203 829 5000
Alexandra Campbell-Harris
| 1 | Details of the person discharging managerial responsibilities | |||||||
| a) | Name | Marcus Yeoman | ||||||
| 2 | Reason for the notification | |||||||
| a) | Position/status | Non-Executive Director | ||||||
| b) | Initial notification/amendment | Initial notification | ||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||
| a) | Name | Medcaw Investments plc | ||||||
| b) | LEI | 213800UTM4MRTZHJ8C21 | ||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||
| a) | Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 1 pence each GB00BM8SQP62 |
||||||
| b) | Nature of the transaction | Acquisition | ||||||
| c) | Price(s) and volume(s) |
|
||||||
| d) | Aggregated information - Aggregated volume - Price |
95,908 £3,487.45 |
||||||
| e) | Date of the transaction | 14th to 16th March 2023 | ||||||
| f) | Place of the transaction | AIM | ||||||
Copyright h 20 PR Newswire
1 Year Medcaw Investments Chart |
1 Month Medcaw Investments Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
